Archives
-
GSK2606414: PERK Inhibitor Assay Guide
2026-09-09
Learn how GSK2606414 (SKU A3448) can help distinguish PERK-dependent ER-stress signaling from nonspecific effects in viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers assay design, dosing, solvent handling, interpretation, and practical product-selection criteria.
-
Nanoparticle mRNA Delivery Reverses Trastuzumab Resistance
2026-09-08
The reference study developed tumor-microenvironment-responsive nanoparticles to deliver PTEN mRNA systemically and restore pathway control in trastuzumab-resistant HER2-positive breast cancer models. Its main contribution is to connect conditional nanoparticle exposure, transient tumor-suppressor expression, and PI3K/Akt signaling pathway inhibition in a single resistance-reversal strategy.
-
BFH772 (VEGFR2 inhibitor) Workflow Guide
2026-09-07
BFH772 is a selective VEGFR2 inhibitor for experiments that require controlled suppression of VEGFR2-associated signaling and angiogenesis-related readouts. Its organic-solvent compatibility supports concentrated stock preparation, but its water insolubility and limited published evidence make it unsuitable for unvalidated aqueous dosing, broad kinase profiling, or direct translation of animal findings into a treatment protocol.
-
Aprotinin in Protease-Controlled RNA Workflows
2026-09-07
Explore how Aprotinin, or bovine pancreatic trypsin inhibitor, can be evaluated as a defined protease-control reagent alongside nascent RNA workflows. This guide connects fibrinolysis inhibition and serine protease biology with the practical assay innovations of an affordable GRO-seq protocol.
-
Fungal IAA Drives Ferroptotic Conidial Death
2026-09-05
A 2026 Molecular Plant Pathology study identifies fungal indole-3-acetic acid (IAA) as an upstream regulator of iron accumulation, lipid peroxidation, autophagy, and ferroptotic death during Magnaporthe oryzae development. Genetic mutants and phosphatidylethanolamine rescue experiments connect IAA-dependent lipid metabolism with appressorium formation and rice blast pathogenicity, while also defining important limits for translating the findings into delivery or formulation research.
-
Caffeic Acid Phenethyl Ester (CAPE) in NF-κB Assays
2026-09-04
Caffeic Acid Phenethyl Ester (CAPE) is a selective NF-κB perturbation tool for dissecting inflammatory signaling. This guide connects CAPE assay design with Fyn–Stat3 neurodegeneration models while defining what the evidence does—and does not—support.
-
EZ Cap™ Human PTEN mRNA (ψUTP) Workflow Guide
2026-09-04
Learn how to use EZ Cap™ Human PTEN mRNA (ψUTP) in mammalian expression, pathway-rescue, and nanoparticle-development workflows. Practical dosing, controls, and troubleshooting guidance helps connect transient PTEN restoration with PI3K/Akt signaling pathway inhibition in cancer research.
-
PXR Activation Blocks Pyroptosis in Cholestatic Injury
2026-09-03
The reference study shows that activating pregnane X receptor with Pregnenolone-16α-carbonitrile protects mice from lithocholic acid-induced cholestatic liver injury by suppressing both canonical and noncanonical hepatocyte pyroptosis. Its mechanistic contribution is to connect PXR signaling with the NF-κB–NLRP3 and FOXO1–APAF-1 axes, offering a framework for studying anti-cholestatic interventions beyond bile acid detoxification.
-
Chronic Stress, Brain Mitochondria, and MnTBAP Rescue
2026-09-03
This rat study links chronic unpredictable mild stress to depression-like behavior, impaired mitochondrial function, and neuroinflammation in the hippocampus and prefrontal cortex. Intracerebroventricular MnTBAP improved the behavioral phenotype, supporting a mechanistic connection between mitochondrial redox imbalance and stress-related brain pathology while leaving important translational questions unresolved.
-
NU7441 (KU-57788): Selective DNA-PK Inhibitor
2026-09-02
NU7441, also called KU-57788, is an ATP-competitive DNA-PK inhibitor with reported nanomolar biochemical potency and strong selectivity over ATM and ATR. It is a research tool for DNA repair research, oncology research, DNA-damage sensitization, and cell-cycle analysis rather than a clinical treatment.
-
HyperScribe™ T7 Kit: RNA Assay Design
2026-09-02
The HyperScribe T7 High Yield RNA Synthesis Kit can support more than bulk transcript production. This article shows how T7 RNA polymerase transcription, labeled RNA design, and assay controls can be aligned with mechanistic studies of LINC02613-driven oral cancer metastasis.
-
Nonselective β-Blockers and Hematopoietic Recovery
2026-09-01
The reference study shows that β-blocker selectivity can influence hematopoietic regeneration after transplantation: carvedilol impaired recovery in mice and was associated with delayed platelet engraftment and lower survival after allogeneic HCT, whereas metoprolol did not produce the same pattern. These findings connect peripheral-nerve adrenergic signaling with transplant outcomes and support careful interpretation of β-blocker exposure in experimental and clinical HCT settings.
-
HOXC8, Caspase-1, and Pyroptosis in NSCLC
2026-09-01
A 2025 Cell Death and Disease study identifies HOXC8 as a transcriptional suppressor of caspase-1 expression in non-small cell lung cancer. Its depletion increases CASP1 abundance and triggers ASC-independent pyroptosis, revealing a tumor-supportive mechanism that links transcriptional repression, gasdermin D pore formation, and lung tumorigenesis.
-
Iptacopan (LNP023) Complement Research Workflows
2026-08-31
Iptacopan (LNP023) enables selective interrogation of alternative-pathway amplification in serum, hemolysis, C3-deposition, and disease-model workflows. This guide connects assay design with translational PNH biomarkers while providing practical controls, protocol parameters, and troubleshooting strategies.
-
Halazone: From Redox Chemistry to Assay Design
2026-08-31
Halazone is an antimicrobial sulfonamide derivative whose value extends from rapid water disinfection to mechanistic membrane electrophysiology. This article translates its chemistry and frog-nerve evidence into practical decisions for antimicrobial resistance research and reproducible assays.